Kaleido Biosciences, Inc. (KLDO)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 17, 2025, 3:00 PM EST
Kaleido Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '21 Dec 31, 2021 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2016 |
| Net Income | -90.29 | -90.29 | -81.62 | -86.33 | -61.74 | -27.56 | Upgrade
|
| Depreciation & Amortization | 2.36 | 2.36 | 1.82 | 1.32 | 0.79 | 0.32 | Upgrade
|
| Other Amortization | 0.71 | 0.71 | 0.7 | 0.04 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.13 | -0.13 | 0.17 | - | 0 | - | Upgrade
|
| Stock-Based Compensation | 10.34 | 10.34 | 12.68 | 10.07 | 6.96 | 0.59 | Upgrade
|
| Other Operating Activities | 0.18 | 0.18 | 0.18 | 0.33 | 1.18 | 0.15 | Upgrade
|
| Change in Accounts Payable | 0.28 | 0.28 | 3.3 | -0.68 | 1.84 | 0.01 | Upgrade
|
| Change in Other Net Operating Assets | -0.54 | -0.54 | 1.25 | -0.53 | 4.66 | 4 | Upgrade
|
| Operating Cash Flow | -77.09 | -77.09 | -61.52 | -75.8 | -46.32 | -22.5 | Upgrade
|
| Capital Expenditures | -1.13 | -1.13 | -4.02 | -3.59 | -3 | -1.41 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.44 | 0.44 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0.69 | -0.69 | -4.02 | -3.59 | -3 | -1.41 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 37.5 | - | 9.96 | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.07 | -30.09 | -0.11 | -0.09 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -0.07 | 7.41 | -0.11 | 9.88 | Upgrade
|
| Issuance of Common Stock | 70.4 | 70.4 | 40.55 | 68.39 | 0.12 | 3.02 | Upgrade
|
| Repurchase of Common Stock | -0.34 | -0.34 | - | - | - | - | Upgrade
|
| Other Financing Activities | -0.02 | -0.02 | -0.08 | -1.16 | -2.08 | -0.06 | Upgrade
|
| Financing Cash Flow | 70.04 | 70.04 | 40.4 | 74.64 | 98.91 | 49.74 | Upgrade
|
| Net Cash Flow | -7.75 | -7.75 | -25.14 | -4.74 | 49.59 | 25.84 | Upgrade
|
| Free Cash Flow | -78.22 | -78.22 | -65.54 | -79.38 | -49.32 | -23.9 | Upgrade
|
| Free Cash Flow Margin | -7085.42% | -7085.42% | -6722.26% | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -1.87 | -1.87 | -1.96 | -3.09 | -9.65 | -5.35 | Upgrade
|
| Cash Interest Paid | 2.13 | 2.13 | 1.93 | 0.88 | 0.94 | 0.34 | Upgrade
|
| Levered Free Cash Flow | -46.02 | -46.02 | -36.73 | -49.72 | -26.4 | -13.59 | Upgrade
|
| Unlevered Free Cash Flow | -44.96 | -44.96 | -35.68 | -49.14 | -25.77 | -13.31 | Upgrade
|
| Change in Net Working Capital | 1.83 | 1.83 | -3.26 | 2.78 | -7.4 | -4.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.